Dr. Kramer, a vocal advocate for the research and therapeutic use of cannabis for animals, is the Medical Director at the VCA-Canada Vancouver Animal Wellness Hospital and has been practicing veterinary medicine for 16 years. She became interested in alternative treatment early in her career, blending herbs and acupuncture with Western medicine to promote optimal health.

Dr. Kramer's study of cannabis is driven by the many successes her patients have had over the past six years and she is considered a pioneer in this field. She has been featured in local and national media in Canada and has become a resource for veterinarians across North America seeking information on the benefits of medicinal cannabis for pets.

"Dr. Kramer is a vital addition to our team and her recognized veterinary knowledge builds on our solid foundation of in-house integrative care, cannabis cultivation, and marketing expertise," said Darcy Bomford, Founder and Chief Executive Officer of True Leaf. "Her experience with medicinal cannabis for pets will be integral to our product development process. Over the years, Dr. Kramer has gathered specific knowledge on the safe use, dosage, and efficacy related to administering cannabis for pets. This knowledge will be key to the success of our upcoming cannabidiol (CBD) product line, scheduled to be launched to the veterinary market next year."

As Chair of True Leaf's Veterinary Advisory Board, Dr. Kramer will recruit veterinarians from around the world to join True Leaf as the company develops legal and safe medicinal cannabis products for pets. She and her colleagues will be instrumental in the research and development of CBD pet products at True Leaf, including the design and execution of supportive trials and the development of education programs for veterinarians and pet owners on the best use of cannabis products for pets.

"True Leaf has established itself as a leader in the pet supplement industry by committing to getting it right and developing products that are safe and effective," said Dr. Kramer. "By assembling a group of top clinicians, together with True Leaf's committed team, I look forward to developing industry-leading therapeutic pet products and being on the forefront of cannabis education and research. Ultimately, it's about returning the love – improving the quality of life for our dearest pet companions with medicinal cannabis."

Dr. Kramer is a member of the Canadian Veterinary Medical Association (CVMA), the College of Veterinarians of British Columbia, the International Veterinary Academy of Pain Management, the International Veterinary Acupuncture Society, and the American Association of Feline Practitioners.

She is also a member of the Canadian Association of Veterinary Cannabinoid Medicine (CAVCM), an organization that is working with the CVMA to encourage Health Canada to amend the Access to Cannabis for Medical Purposes Regulations (ACMPR) to permit the future classification of CBD as a Veterinary Health Product. This would open the door for True Leaf to bring legal, safe, and quality-controlled CBD products for pets to market in Canada.

About True Leaf

True Leaf is a plant-forward wellness brand for people and their pets. Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc.

True Leaf Medicine Inc. is in the final stages of approval to become a licensed producer of federally-approved medicinal cannabis for the Canadian market. The license is subject to a Health Canada inspection to allow for the production, manufacture, and distribution of cannabis products upon the completion of True Leaf Campus: the company's cannabis cultivation facility being built in Lumby, British Columbia. Construction is expected to be completed in fall 2018.

Established in 2015, True Leaf Pet Inc. is one of the first companies to market hemp-based products for pets worldwide. The company is initially marketing a line of hemp-seed based supplements for pets. True Hemp™ chews, dental sticks, and supplement oils are sold in more than 1,800 stores across North America and Europe.

This news release contains forward-looking statements and management may make additional forward-looking statements in response to your questions. Such written and oral disclosures are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995 and True Leaf hereby claims such safe harbour protection for all forward-looking statements. True Leaf believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions; however, True Leaf's actual results and performance and the value of its securities could differ materially from those set forth in the forward-looking statements due to the impact of many factors summarized in the "Risk Factors" section of True Leaf's Offering Circular Form 1-A filed with the U.S. Securities and Exchange Commission and Canadian securities regulatory authorities and other discussions of risk factors contained in True Leaf's periodic filings or supplements to the offering circular. True Leaf's Offering Circular Form 1-A can be found at www.trueleaf.com/pages/investor. Forward-looking statements speak only as of the date they are made. True Leaf undertakes no obligation to update or revise any such information for any reason after the date of this presentation unless required by law.